Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 256

Sort by

Sort Order Select

Journal Articles

The characterization of distinct populations of murine skeletal cells that have different roles in B lymphopoiesis

Alanna C. Green, Gavin Tjin, Samuel C. Lee, Alistair M. Chalk, Lenny Straszkowski, Diannita Kwang, Emma K. Baker, Julie M. Quach, Takaharu Kimura, Joy Y. Wu, Louise E. Purton

Blood (2021) 138 (4): 304–317.

https://doi.org/10.1182/blood.2020005865

Published: 2021

Includes: Supplemental data

Journal Articles

Imatinib +/- Brentuximab Vedotin Induces Sustained Complete Remission in Chemotherapy-Resistant Anaplastic Large Cell Lymphoma Expressing PDGFR

Philipp Bernhard Staber, MD PhD, Christoph Kornauth, Ines Garces de los Fayos Alonso, Wilhelm Woessmann, MD, Wolfram Klapper, Sabine Lagger, Ana-Iris Schiefer, Cathrin Skrabs, Olaf Merkel, PhD, Marius E Mayerhoefer, Richard Greil, MD, Ingrid Simonitsch-Klupp, MD, Lukas Kenner, MD, Ulrich Jaeger, MD

Blood (2019) 134 (Supplement_1): 4037.

https://doi.org/10.1182/blood-2019-129955

Published: 2019

Journal Articles

Novel CD4 + CD8 + Umbilical Cord Blood Regulatory T Cells

Meixian Huang, Amit Verma, MBBS, Ke Zeng, MD PhD, Mi-Ae Lyu, PhD, Mitsutaka Nishimoto, MD PhD, Hongbing Ma, MD PhD, Zheng Yin, PhD, Swaminathan P. Iyer, MD, Simrit Parmar, MBBS

Blood (2019) 134 (Supplement_1): 4446.

https://doi.org/10.1182/blood-2019-131948

Published: 2019

Journal Articles

Secreted Factors Determine Resistance to Idelalisib in Marginal Zone Lymphoma Models of Resistance

Alberto J Arribas, Sara Napoli, Eugenio Gaudio, PhD, Luciano Cascione, PhD, Alessandra Di Veroli, Chiara Tarantelli, PhD, Filippo Spriano, Antonella Zucchetto, Francesca Maria Rossi, PhD, Andrea Rinaldi, Anastasios Stathis, MD, Georg Stuessi, MD, Valter Gattei, MD, Gabriele Cruciani, Emanuele Zucca, MD, Davide Rossi, MD PhD, Francesco Bertoni, MD

Blood (2019) 134 (Supplement_1): 2569.

https://doi.org/10.1182/blood-2019-124299

Published: 2019

Journal Articles

A Naturally Occurring Canine Model of Peripheral T-Cell Lymphoma Not Otherwise Specified

Lauren Harris, VMD, Emily Rout, DVM, Janna Yoshimoto, BS, Anne Avery, VMD, PhD

Blood (2018) 132 (Supplement 1): 4105.

https://doi.org/10.1182/blood-2018-99-120034

Published: 2018

Journal Articles

Engraftment and Reconstitution of Hematopoiesis Is Dependent on Endothelial Cell Expressed Prostaglandin EP4 Receptor Signaling Mediated Regeneration of Vascular Niche

Pratibha Singh, PhD, Hongge Li, PhD, Louis M. Pelus, PhD

Blood (2018) 132 (Supplement 1): 1293.

https://doi.org/10.1182/blood-2018-99-119723

Published: 2018

Journal Articles

Preclinical Rationale for the Use of Regorafenib in Myeloid Malignancies

Gabriela S. Hobbs, MD, Andrew M. Brunner, MD, Timothy A. Graubert, MD, Cyril H Benes, Gabriel Daniel Duda, DMD, PhD, Yi-Bin Chen, MD

Blood (2017) 130 (Supplement 1): 2643.

https://doi.org/10.1182/blood.V130.Suppl_1.2643.2643

Published: 2017

Journal Articles

Comprehensive Genetic Characterization of 63 Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFR-α, PDGFR-β, FGFR1 or PCM1-JAK2

Constance Regina Baer, PhD, Verena Muehlbacher, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 4219.

https://doi.org/10.1182/blood.V130.Suppl_1.4219.4219

Published: 2017

Journal Articles

Imatinib Induces Apoptosis of NK/T Cell Neoplasms by Inhibiting Hematopoietic Cell Kinase and NQO2

Takeshi Yoroidaka, MD, Luis Espinoza, MDPhD, Kenichi Harada, MD PhD, Ly Quoc Trung, MD PhD, Shinji Nakao, MD PhD

Blood (2017) 130 (Supplement 1): 1270.

https://doi.org/10.1182/blood.V130.Suppl_1.1270.1270

Published: 2017

Journal Articles

High PDGFRA Expression Does Not Serve As Effective Therapeutic Target in ERG -Deleted B-Cell Precursor Acute Lymphoblastic Leukemia

Isabel S. Jerchel, MSc, Judith M. Boer, PhD, Alex Q. Hoogkamer, BSc, H. Berna Beverloo, PhD, Rob Pieters, MD PhD, Monique L. den Boer, PhD

Blood (2017) 130 (Supplement 1): 1274.

https://doi.org/10.1182/blood.V130.Suppl_1.1274.1274

Published: 2017

Journal Articles

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Udo Zur Stadt, PhD, Malik Alawi, M. Sc., Gabriele Escherich, MD, Martin A. Horstmann, MD

Blood (2017) 130 (Supplement 1): 2715.

https://doi.org/10.1182/blood.V130.Suppl_1.2715.2715

Published: 2017

Journal Articles

Altered Expression of Pdgfrα and Its Downstream Signalling Components May be Causal in the Development of Imatinib Induced Thrombocytopenia in CML Patients Receiving Imatinib Treatment

Sameer Ahmad Guru, Musadiq Ahmad Bhat, MSc., Imtiyaz Ahmad Najar, PhD, Ab. Rashid Rashid, PhD, Mariyam Zuberi, PhD, Mamta Sumi Sumi, PhD, Naresh Gupta, MD, Alpana Saxena, Ajay Sharma, MD

Blood (2017) 130 (Supplement 1): 1627.

https://doi.org/10.1182/blood.V130.Suppl_1.1627.1627

Published: 2017

Journal Articles

Predictive Simulation Modeling in JAK2-Mutant MPNs Identified Ruxolitinib and Sorafenib As a Synergistic Drug Combination for Disease Modifying Therapy

Peter P. Sayeski, PhD, Leylah M. Drusbosky, PhD, Neeraj Kumar Singh, B.Tech, Anusha Pampana, Shahabuddin Usmani, MS, Mohammed Sauban, BE, Abha Kushwaha, Anu Ramakrishnan, Taher Abbasi, MS, MBA, Shireen Vali, PhD, Christopher R. Cogle, MD

Blood (2017) 130 (Supplement 1): 5287.

https://doi.org/10.1182/blood.V130.Suppl_1.5287.5287

Published: 2017

Journal Articles

A New Sensitive and Fast Molecular Analysis Method for the Identification of 30 Different Markers in Acute Myeloid and Lymphoid Leukemias at Diagnosis Time

Emilia Giugliano, Roberta Lorenzatti, Dr., Enrico Marco Gottardi, Dr., Chiara Sammartino, Dr., Roberta Toja, Francesca Crasto, Dr, Alessandro Volpengo, Dr, Cristina Fantino, Dr, Filomena Daraio, PhD, Anna Serra, Dr, Francesca Carnuccio, Dr, Giuseppe Saglio, MD PhD, Angelo Guerrasio, MD

Blood (2017) 130 (Supplement 1): 5097.

https://doi.org/10.1182/blood.V130.Suppl_1.5097.5097

Published: 2017

Journal Articles

Integrated Functional Genomic and Pharmacological Characterization of the Kinome of Myeloma Cells

Ricardo De Matos Simoes, PhD, Eugen Dhimolea, PhD, Ryosuke Shirasaki, MD PhD, Sara Gandolfi, MD, Geoffrey Matthews, PhD, Michal Sheffer, PhD, Olga Dashevsky, PhD, Brian Glassner, PhD, Constantine S. Mitsiades, MD PhD

Blood (2017) 130 (Supplement 1): 2501.

https://doi.org/10.1182/blood.V130.Suppl_1.2501.2501

Published: 2017

Journal Articles

One size doesn’t fit all in Ph-like ALL

Sean M. Post

Blood (2017) 129 (2): 140–141.

https://doi.org/10.1182/blood-2016-11-749168

Published: 2017

Journal Articles

Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia

Sarah K. Tasian, David T. Teachey, Yong Li, Feng Shen, Richard C. Harvey, I-Ming Chen, Theresa Ryan, Tiffaney L. Vincent, Cheryl L. Willman, Alexander E. Perl, Stephen P. Hunger, Mignon L. Loh, Martin Carroll, Stephan A. Grupp

Blood (2017) 129 (2): 177–187.

https://doi.org/10.1182/blood-2016-05-707653

Published: 2017

Includes: Supplemental data

Journal Articles

A Network of Activated Cancer Signaling Pathways in a High Risk Subgroup of Acute Myeloid Leukemia Targetable By SRC-Kinase Inhibitors

Claudia Chiriches, PhD, Dilawar Khan, PhD, Nathalie Guillen, PhD, Michal Rokicki, Carol Guy, Afsar Mian, PhD, Oliver G. Ottmann, MD, Martin Ruthardt, MD

Blood (2016) 128 (22): 2746.

https://doi.org/10.1182/blood.V128.22.2746.2746

Published: 2016

Journal Articles

Clonal Events of Aplastic Anemia Related to the Evolution to Myelodysplastic Syndrome

Eiju Negoro, MD, PhD, Michael Clemente, M.S., Naoko Hosono, MD,PhD, Aziz Nazha, MD, Wenyi Shen, MD, Yasunobu Nagata, MD, PhD, Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Reda Z. Mahfouz, MD, PhD, Teodora Kuzmanovic, BSc, Hideki Makishima, MD PhD FACP., Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 4290.

https://doi.org/10.1182/blood.V128.22.4290.4290

Published: 2016

Journal Articles

CRLF2 Rearrangement Status in Ph-like ALL Predicts Intrinsic Glucocorticoid Resistance In Vitro that is Reversible with Targeted MAPK and PI3K Pathway Inhibition

Lauren K Meyer, Cristina Delgado-Martin, PhD, Shannon L Maude, MD PhD, David T Teachey, MD, Michelle L. Hermiston, MD PhD

Blood (2016) 128 (22): 910.

https://doi.org/10.1182/blood.V128.22.910.910

Published: 2016

NARROW

The characterization of distinct populations of murine skeletal cells that have different roles in B lymphopoiesis

Imatinib +/- Brentuximab Vedotin Induces Sustained Complete Remission in Chemotherapy-Resistant Anaplastic Large Cell Lymphoma Expressing PDGFR

Novel CD4 + CD8 + Umbilical Cord Blood Regulatory T Cells

Secreted Factors Determine Resistance to Idelalisib in Marginal Zone Lymphoma Models of Resistance

A Naturally Occurring Canine Model of Peripheral T-Cell Lymphoma Not Otherwise Specified

Engraftment and Reconstitution of Hematopoiesis Is Dependent on Endothelial Cell Expressed Prostaglandin EP4 Receptor Signaling Mediated Regeneration of Vascular Niche

Preclinical Rationale for the Use of Regorafenib in Myeloid Malignancies

Comprehensive Genetic Characterization of 63 Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFR-α, PDGFR-β, FGFR1 or PCM1-JAK2

Imatinib Induces Apoptosis of NK/T Cell Neoplasms by Inhibiting Hematopoietic Cell Kinase and NQO2

High PDGFRA Expression Does Not Serve As Effective Therapeutic Target in ERG -Deleted B-Cell Precursor Acute Lymphoblastic Leukemia

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Altered Expression of Pdgfrα and Its Downstream Signalling Components May be Causal in the Development of Imatinib Induced Thrombocytopenia in CML Patients Receiving Imatinib Treatment

Predictive Simulation Modeling in JAK2-Mutant MPNs Identified Ruxolitinib and Sorafenib As a Synergistic Drug Combination for Disease Modifying Therapy

A New Sensitive and Fast Molecular Analysis Method for the Identification of 30 Different Markers in Acute Myeloid and Lymphoid Leukemias at Diagnosis Time

Integrated Functional Genomic and Pharmacological Characterization of the Kinome of Myeloma Cells

One size doesn’t fit all in Ph-like ALL

Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia

A Network of Activated Cancer Signaling Pathways in a High Risk Subgroup of Acute Myeloid Leukemia Targetable By SRC-Kinase Inhibitors

Clonal Events of Aplastic Anemia Related to the Evolution to Myelodysplastic Syndrome

CRLF2 Rearrangement Status in Ph-like ALL Predicts Intrinsic Glucocorticoid Resistance In Vitro that is Reversible with Targeted MAPK and PI3K Pathway Inhibition

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only